Limitations, agreements, and source contact

Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma · Source last updated 2015-07-31

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

Low accrual led to early termination; only one subject was enrolled.

point Of Contact

email

dcandelaria@salud.unm.edu

organization

University of New Mexico

phone

505-272-4661

title

Dulcinea Quintana, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice